L. Nielsen (Aarhus, Denmark), D. Spina (London, United Kingdom)
Efficacy of inhaled heparin is effective in the treatment of acute exacerbation of asthma M. Elprince, N. Abdelaty (Ismailia, Egypt)
| |
Inhaled IL-4/IL-13 antagonist decreases response to antigen challenge in atopic asthmatic subjects D. Wilbraham, E. Burmeister Getz, M. Longphre, S. Wenzel, R. Fuller (London, United Kingdom; Berkeley, CA, Pittsburgh, PA, United States Of America)
| |
Does atorvastatin have effect on lung function and morbidity as add-on therapy in asthmatic patients? F. Fahimi, S. Sohrabi, H. Jamaati, Z. Mohammad Taheri, A. Fakharian, J. Salamzadeh (Tehran, Islamic Republic Of Iran)
| |
High molecular weight preparations of hyaluronic acid protect asthmatics from challenge-induced bronchoconstriction, while a low molecucular weight preparation does not L. Allegra, T. Cappelletti, S. Della Patrona, V. Fasano, G. Petrigni (Milan, Italy)
| |
Influence of ramatroban and montelukast on the early asthmatic response S. Heinemann, J. Welling, C. Martin, P. Zabel, S. Uhlig (Borstel, Aachen, Germany)
| |
The effect of nebulised MgSO4 on lung function in stable severe asthma patients with persistent airflow limitation A. Zandsteeg, P. Hirmann, J. P. Yska, A. Ten Brinke (Leeuwarden, Netherlands)
| |
The inhaled PDE4 inhibitor UK-500,001 does not significantly inhibit airway responses to allergen and histamine P. Phillips, M. Bennetts, K. Banner, J. Ward, D. Wessels, R. Fuhr (Sandwich, London, United Kingdom; Berlin, Germany)
| |
Tiotropium bromide inhibits airway eosinophilia in allergen-challenged guinea pigs J. Zaagsma, S. Bos, R. Gosens, H. Meurs (Groningen, Netherlands)
| |